Shares of Cannabics Pharmaceuticals Inc. (OTCMKTS:CNBX) fell 10.4% on Tuesday . The company traded as low as $0.19 and last traded at $0.22. 1,502,046 shares changed hands during mid-day trading, an increase of 209% from the average session volume of 486,254 shares. The stock had previously closed at $0.25.
The firm has a 50-day simple moving average of $0.34 and a 200-day simple moving average of $0.28.
Cannabics Pharmaceuticals Company Profile (OTCMKTS:CNBX)
Cannabics Pharmaceuticals Inc, a biopharmaceutical company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. The company focuses on developing and marketing bioinformatic delivery systems for cannabinoids, personalized medicine therapies, and procedures based on cannabis originated compounds and bioinformatics tools.
Featured Story: How is the Producer Price Index calculated?
Receive News & Ratings for Cannabics Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannabics Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.